These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2543550)

  • 1. The tumor cells (FA-6) established from a pancreatic cancer associated with humoral hypercalcemia of malignancy: a simultaneous production of parathyroid hormone-like activity and transforming growth factor activity.
    Nagata N; Akatsu T; Kugai N; Yasutomo Y; Kinoshita T; Kosano H; Shimauchi T; Takatani O; Ueyama Y
    Endocrinol Jpn; 1989 Feb; 36(1):75-85. PubMed ID: 2543550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascites sarcoma 180, an animal model of humoral hypercalcemia of malignancy, produces a factor(s) exhibiting potent bone-resorbing activity without any parathyroid hormone-like activity.
    Suzuki K; Yamada S
    Bone Miner; 1991 Jul; 14(1):1-13. PubMed ID: 1651137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
    Merryman JI; Rosol TJ; Brooks CL; Capen CC
    Endocrinology; 1989 May; 124(5):2456-63. PubMed ID: 2539981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a parathyroid hormone-like factor-producing esophageal carcinoma cell line (EC-GI).
    Sato K; Kasono K; Ohba Y; Yashiro T; Fujii Y; Yoshida MA; Tsushima T; Shizume K
    Jpn J Cancer Res; 1987 Oct; 78(10):1044-8. PubMed ID: 2824416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
    Bringhurst FR; Bierer BE; Godeau F; Neyhard N; Varner V; Segre GV
    J Clin Invest; 1986 Feb; 77(2):456-64. PubMed ID: 3003159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascites sarcoma 180, a tumor associated with hypercalcemia, secretes potent bone-resorbing factors including transforming growth factor alpha, interleukin-1 alpha and interleukin-6.
    Suzuki K; Yamada S
    Bone Miner; 1994 Dec; 27(3):219-33. PubMed ID: 7696888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of interleukin-1 alpha and a parathyroid hormone-like factor by a squamous cell carcinoma of the esophagus (EC-GI) derived from a patient with hypercalcemia.
    Sato K; Fujii Y; Kasono K; Tsushima T; Shizume K
    J Clin Endocrinol Metab; 1988 Sep; 67(3):592-601. PubMed ID: 3261732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of cyclic adenosine monophosphate content in bone cells by the factor extracted from a pancreatic cancer associated with hypercalcemia.
    Nagata N; Kugai N; Maemura M; Akatsu T; Shimauchi T; Kinoshita T; Kosano H; Takatani O; Tsuda H; Fuse Y
    Metabolism; 1986 Jun; 35(6):529-34. PubMed ID: 3012245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of parathyroid hormone-like activity from human T-cell lymphotropic virus type I-infected lymphocytes.
    Fukumoto S; Matsumoto T; Watanabe T; Takahashi H; Miyoshi I; Ogata E
    Cancer Res; 1989 Jul; 49(14):3849-52. PubMed ID: 2544261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
    Nagata N; Yasutomo Y; Kugai N; Matsuura Y; Akatsu T; Sugiyama K; Kinoshita T; Takatani O; Mamiya Y; Yamaguchi K
    Jpn J Clin Oncol; 1989 Dec; 19(4):353-9. PubMed ID: 2558242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy.
    Insogna KL; Weir EC; Wu TL; Stewart AF; Broadus AE; Burtis WJ; Centrella M
    Endocrinology; 1987 May; 120(5):2183-5. PubMed ID: 3494596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy.
    Ibbotson KJ; D'Souza SM; Smith DD; Carpenter G; Mundy GR
    Endocrinology; 1985 Jan; 116(1):469-71. PubMed ID: 2981075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of renal membrane adenylate cyclase by extract of pancreatic cancer associated with humoral hypercalcemia of malignancy.
    Yasutomo Y; Kugai N; Nagata N; Akatsu T; Wada S; Kinoshita T; Kosano H; Takatani O
    Bone Miner; 1990 May; 9(2):111-20. PubMed ID: 2161691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.
    Sato K; Fujii Y; Kasono K; Ozawa M; Imamura H; Kanaji Y; Kurosawa H; Tsushima T; Shizume K
    Endocrinology; 1989 May; 124(5):2172-8. PubMed ID: 2539970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA; Yoneda T; Yates AJ; Mundy GR
    J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the activities of parathyroid hormone-like factor and transforming growth factors in extract of pancreatic cancer associated with humoral hypercalcemia of malignancy.
    Akatsu T; Nagata N; Kugai N; Yasutomo Y; Kinoshita T; Kosano H; Takatani O; Takishima K; Mamiya G
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):232-8. PubMed ID: 3164557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.
    Linkhart TA; Mohan S; Jennings JC; Baylink DJ
    Cancer Res; 1989 Jan; 49(2):271-8. PubMed ID: 2535957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy.
    D'Souza SM; Ibbotson KJ; Mundy GR
    J Clin Invest; 1984 Sep; 74(3):1104-7. PubMed ID: 6470137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.
    Minkin C; Fredericks RS; Pokress S; Rude RK; Sharp CF; Tong M; Singer FR
    J Clin Endocrinol Metab; 1981 Nov; 53(5):941-7. PubMed ID: 6793615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of bone-resorbing activity and colony-stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis.
    Sato K; Mimura H; Han DC; Kakiuchi T; Ueyama Y; Ohkawa H; Okabe T; Kondo Y; Ohsawa N; Tsushima T
    J Clin Invest; 1986 Jul; 78(1):145-54. PubMed ID: 3487554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.